Skip to main content
Equibles

David LaPre

Board Member

Calidi Biotherapeutics, Inc. (CLDI)

Equibles does not estimate personal net worth.

Get an email with a short summary when Calidi Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CLDI alerts

About David LaPre

David LaPre is recorded as Board Member at Calidi Biotherapeutics, Inc. (CLDI) since January 1, 2024. Calidi Biotherapeutics, Inc. reported in an 8-K filed May 16, 2024 that David LaPre resigned as director, effective May 10, 2024. Calidi Biotherapeutics, Inc. reported in an 8-K filed December 12, 2023 that David LaPre was appointed director, effective January 1, 2024. Calidi Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Calidi Biotherapeutics, Inc. includes Eric Poma, Ph.D. (CEO and Board Member), Thomas A. Vecchiolla (CEO and Chairman), James Schoeneck (Chairman and Board Member) and 7 others.

“On May 10, 2024, Mr. David LaPre notified the Board of Directors (the “Board”) of Calidi Biotherapeutics, Inc. (the “Company”) of his resignation as a director of the Company, including his position on each Board committee on which he served, effective immediately.”
Calidi Biotherapeutics, Inc. Form 8-K, filed May 16, 2024 · Read the filing
“On November 8, 2023, the Board appointed Mr. David LaPre as a director to fill the vacancy in connection with Mr. Vecchiolla's departure, effective January 1, 2024.”
Calidi Biotherapeutics, Inc. Form 8-K, filed December 12, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Calidi Biotherapeutics, Inc.

Recent activity